Nanotechnology-based mRNA vaccines
2023 · Nature Reviews Methods Primers · 143 citations
https://doi.org/10.1038/s43586-023-00246-7
Y
Yonger Xue
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
1.5K
Citations
17
h-index
24
i10-index
Yonger Xue is an academic researcher from Allen Institute for Brain Science. The author has contributed to research in topics: RNA Interference and Gene Delivery & Immunotherapy and Immune Responses & Advanced biosensing and bioanalysis techniques. The author has an h-index of 17, co-authored 29 publications.
ORCID: 0000-0002-6022-2487Papers by this author
worksBlood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system
2025 · Nature Materials · 94 citations
https://doi.org/10.1038/s41563-024-02114-5
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
2024 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-024-44963-3
LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing
2024 · Nature Communications · 68 citations
https://doi.org/10.1038/s41467-024-45094-5
LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment
2025 · Nature Communications · 17 citations
https://doi.org/10.1038/s41467-025-57149-2
CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
2025 · Journal of Nanobiotechnology · 1 citations
https://doi.org/10.1186/s12951-025-03128-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat